Targeting tumor-specific inflammatory processes in colorectal cancer could enhance the efficacy of some anticancer therapies and prevent drug resistance, Weill Cornell researchers have found.
As the 2025–26 academic year comes to a close, Cornell Tech will host a series of events throughout May showcasing student achievement, entrepreneurship, design, and the future of emerging technologies.
Activated immune cells secrete tiny capsules bearing DNA that can enter other immune and tumor cells to stimulate the body’s defense systems, according to a study led by investigators at Weill Cornell Medicine.
Researchers found that nerves of the sympathetic nervous system are often abundant in melanomas, and can inhibit tumor growth by reducing local tumor-supportive macrophages.
Weill Cornell Medicine investigators made an unexpected finding that could open new avenues for therapies against inflammatory bowel disease, food allergy and other autoimmune conditions.
